BARCELONA—The establishment of the Scientific Advisory Board (SAB) represents a step forward in the consolidation of the Euroepean Foundation for the Study of Chronic Liver Failure (EF CLIF). The SAB is constituted by 12 members that will meet every year to review EF CLIF activities and draft a report highlighting areas of improvement and recommendations for further development.
Image: © European Foundation for the Study of Chronic Liver Failure.
Members of the SAB were invited to attend a first meeting at the EF CLIF Headquarters in Barcelona, Spain, on 4 April 2022, where the EF CLIF Director, Chair of the EASL-CLIF Consortium Steering Committee and Principal Investigators at EF CLIF presented major achievements and milestones in the previous 5 year.
Members of the Scientific Advisory Board
Chair
Richard Moreau
Hôpital Beaujon, France
European Foundation for the Study of Chronic Liver Failure, Spain
Secretary
Jonel Trebicka
Universitätsklinikum Münster, Germany
European Foundation for the Study of Chronic Liver Failure, Spain
Appointed members
Paolo Caraceni
University of Bologna, Italy
Helena Cortez-Pinto
University of Lisbon, Portugal
Tom Hemming Karlsen
University of Oslo, Norway
Sophie Lotersztain
Center for Research in Inflammation, University of Paris, INSERM U1149, France
Mala K. Maini
University College London, UK
Giuliana Magri
Hospital del Mar Research Institute, Spain
José María Mato
CICbioGUNE, Spain
Jean-Charles Nault
Hôpital Avicenne, France
Cordeliers Research Center, University of Paris, INSERM UMR 138, France
Frank Tacke
Charité – Universitätsmedizin Berlin, Germany
Eric Trépo
CUB Hôpital Erasme – Université Libre de Bruxelles, Belgium
Luca Valenti
University of Milan, Italy
Jessica Zucman-Rossi
Cardeliers Research Center, University of Paris, INSERM UMR 1138, France